Nuvectis Pharma Files Definitive Proxy Statement
Ticker: NVCT · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1875558
| Field | Detail |
|---|---|
| Company | Nuvectis Pharma, Inc. (NVCT) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Nuvectis Pharma's proxy statement is out for the June 12 meeting. Vote your shares!
AI Summary
Nuvectis Pharma, Inc. filed its definitive proxy statement on April 28, 2025, for its annual meeting scheduled for June 12, 2025. The filing, designated as DEF 14A, outlines the company's governance and proposals to be voted on by shareholders. Nuvectis Pharma is a pharmaceutical preparations company incorporated in Delaware.
Why It Matters
This filing is crucial for shareholders as it details the agenda for the annual meeting, including director elections and other corporate matters, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing for an annual meeting, not indicating new financial risks or significant operational changes.
Key Players & Entities
- Nuvectis Pharma, Inc. (company) — Registrant
- 0001104659-25-040225 (filing_id) — Accession Number
- 20250428 (date) — Filing Date
- 20250612 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the definitive proxy statement for Nuvectis Pharma, Inc.'s annual meeting of shareholders, scheduled for June 12, 2025.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on April 28, 2025.
What is the company's Central Index Key (CIK)?
Nuvectis Pharma, Inc.'s Central Index Key (CIK) is 0001875558.
Where is Nuvectis Pharma, Inc. headquartered?
Nuvectis Pharma, Inc.'s business address is 1 Bridge Plaza, Suite 275, Fort Lee, NJ 07024.
What is the Standard Industrial Classification (SIC) code for Nuvectis Pharma, Inc.?
The Standard Industrial Classification (SIC) code for Nuvectis Pharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Nuvectis Pharma, Inc. (NVCT).